EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non-alcoholic fatty liver disease: Update on treatment options and translational implications of sleep disruption

Steve M D’Souza, Byung S Yoo, Kevin V Houston, Ankit J Patel, Parth J Parekh, David A Johnson

Annals of Clinical Gastroenterology and Hepatology · 2021

DOI: 10.29328/journal.acgh.1001030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical Gastroenterology and Hepatology, 2021. Verfasst von Steve M D’Souza und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-alcoholic fatty liver disease (NAFLD) is a condition that is associated with cirrhosis and hepatocellular carcinoma, and is increasing in prevalence worldwide. Sleep disruptions are commonly seen in NAFLD, and the disease process is associated with sleep disorders, including obstructive sleep apnea, circadian rhythm disorders, and insufficient sleep. The intermittent hypoxia seen in obstructive sleep apnea may contribute to fibrotic changes in the liver. A major component of this linkage may be related to gut microbiome changes. One notable change is increase in Bacteroidetes/Firmicutes ratio, and decrease in flora that ferment fiber into anti-inflammatory short-chain fatty acids. Several therapeutic options exist for NAFLD that target both sleep and NAFLD, including non-pharmacological factors, such as lifestyle modification (mainly diet and exercise). Pharmacological options include melatonin, Vitamin E, thiazolidinediones, and fecal microbiota transplantation.

Zitieren

APA

D’Souza, S. M., Yoo, B. S., Houston, K. V., Patel, A. J., Parekh, P. J., & Johnson, D. A. (2021). Non-alcoholic fatty liver disease: Update on treatment options and translational implications of sleep disruption. Annals of Clinical Gastroenterology and Hepatology. https://doi.org/10.29328/journal.acgh.1001030

Vancouver

D’Souza SM, Yoo BS, Houston KV, Patel AJ, Parekh PJ, Johnson DA. Non-alcoholic fatty liver disease: Update on treatment options and translational implications of sleep disruption. Annals of Clinical Gastroenterology and Hepatology. 2021. doi:10.29328/journal.acgh.1001030

BibTeX
@article{DSouza2021,
  author = {D’Souza, Steve M and Yoo, Byung S and Houston, Kevin V and Patel, Ankit J and Parekh, Parth J and Johnson, David A},
  title = {Non-alcoholic fatty liver disease: Update on treatment options and translational implications of sleep disruption},
  journal = {Annals of Clinical Gastroenterology and Hepatology},
  year = {2021},
  doi = {10.29328/journal.acgh.1001030}
}
Kostenlos starten →